ABX-1431

DB16036InvestigationalSmall molecule

ABX-1431 is under investigation in clinical trial NCT03625453 (Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder).

Mechanism: Pharmacologically active on Monoglyceride lipase
Curator reviewed
Formula / weight: C₂₀H₂₂F₉N₃O₂ · 507.401 g/mol (avg)
Code names: ABX-1431

Resolves to

Compound

UNIIFB39E94UXKCAS1446817-84-0ChEMBLCHEMBL3945728

Structure

InChIKeySQZJGTOZFRNWCX-UHFFFAOYSA-NSMILESFC(F)(F)C(OC(=O)N1CCN(CC2=CC=C(C=C2N2CCCC2)C(F)(F)F)CC1)C(F)(F)F

Targets

Q99685MGLL

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with ABX-1431, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account